Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Role of Vitamins in Maintaining Bone Health

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

Essential Minerals for Bone Health

Essential Minerals for Bone Health

The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

In vitro activity of eravacycline and comparators against Gram-negative and Gram-positive bacterial isolates collected from patients globally between 2017 and 2020.

Journal of global antimicrobial resistance·2023

Same author

An update on contraceptive therapy options.

American journal of therapeutics·2012

Same author

Obstetrical opportunities: will pharmacy ever realize them?

The Annals of pharmacotherapy·2012

Same author

Changing oral contraceptives from prescription to over-the-counter status: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.

Pharmacotherapy·2011

Same author

Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.

The Annals of pharmacotherapy·2009

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

An update on osteoporosis.

Beth Nochowitz¹, Sherry Siegert, Mitzi Wasik

¹Department of Pharmaceutical Services, University of Chicago Medical Center, Chicago, IL, USA.

American Journal of Therapeutics

|March 6, 2009

Summary

This summary is machine-generated.

Osteoporosis is a silent skeletal disease affecting millions, leading to fractures and increased mortality without intervention. Early diagnosis and individualized treatment are crucial for optimal outcomes, especially with an aging population.

Related Experiment Videos

Last Updated: Jun 25, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Area of Science:

Orthopedics
Gerontology
Public Health

Background:

Osteoporosis is a prevalent skeletal disease in the United States, impacting over 25 million individuals.
It often progresses asymptomatically, leading to compromised bone density and increased fracture risk.
Untreated osteoporosis significantly elevates risks of morbidity and mortality.

Purpose of the Study:

To highlight the critical need for early diagnosis and intervention in osteoporosis management.
To emphasize the importance of individualized therapeutic approaches due to diverse treatment options.
To underscore the growing significance of osteoporosis prevention and treatment in an aging population.

Main Methods:

This abstract is based on a review of current understanding and epidemiological data regarding osteoporosis.
It synthesizes information on the clinical implications and management strategies for osteoporosis.
The text emphasizes the projected demographic shifts and their impact on public health needs.

Main Results:

Osteoporosis leads to fractures, causing decreased daily activity, pain, and loss of independence.
Delayed diagnosis and treatment correlate with higher complication rates and mortality.
The aging American population (over 65) will double by 2050, increasing the burden of osteoporosis.

Conclusions:

Early detection and prompt, individualized treatment are essential for managing osteoporosis effectively.
Preventative measures and therapeutic interventions are vital for mitigating the severe consequences of osteoporosis.
Addressing osteoporosis is crucial for maintaining patient quality of life and reducing healthcare burdens, particularly in light of demographic trends.